| Summary | Fluorochem supplies over 400,000 high-quality chemicals and reagents globally, with custom synthesis and contract manufacturing capabilities for pharmaceutical and life sciences research. | Small molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation. |
|---|
| Locations | - Headquarters, Hadfield, Derbyshire, United Kingdom
- EU Office, Cork, Cork, Ireland
- Headquarters, United Kingdom
| - Cork, Cork, Munster, Ireland
- Cramlington, Cramlington, Northumberland, United Kingdom
- Deeside, Deeside, Wales, United Kingdom
- Newcastle Biosphere, Newcastle, Tyne and Wear, United Kingdom
- North Carolina, North Carolina, North Carolina, United States
- Wisconsin, Wisconsin, Wisconsin, United States
- North Carolina, North Carolina, North Carolina, US
- Wisconsin, Wisconsin, Wisconsin, US
- Newcastle Biosphere, Newcastle, England, UK
- North Carolina, North Carolina, US
- Wisconsin, Wisconsin, US
- Cramlington, Cramlington, England, UK
- North Carolina, North Carolina, North Carolina, USA
- Wisconsin, Wisconsin, Wisconsin, USA
|
|---|
| Certifications | - ISO · Identifier: ISO-Certified for Quality Assurance
- BSI · Identifier: ISO 9001
| - FDA · Identifier: cGMP inspection
- HPRA · Identifier: cGMP inspection (mutually recognised by FDA)
- PMDA · Identifier: Project specific inspection
- ANVISA · Identifier: Project specific inspection
- MHRA · Identifier: cGMP inspection
- DEA · Identifier: Schedule I-V controlled substances approval
- ISO · Identifier: ISO/IEC 27001:2022, ISO/IEC 9001:2015, ISO 45001:2018, ISO 14001:2015
- FDA · Identifier: cGMP inspection January 2017
- PMDA · Identifier: project specific inspection June 2022
- HPRA · Identifier: cGMP inspection March 2022
- ANVISA · Identifier: project specific inspection 2021
- MHRA · Identifier: cGMP inspection June 2021
- FDA · Identifier: cGMP inspection May 2018
- MHRA · Identifier: cGMP inspection April 2023
- FDA · Identifier: Registered as bulk API manufacturer
- DEA · Identifier: Approved to import, store, manufacture and export Schedule I-V controlled substances
- FDA · Identifier: cGMP inspection March 2024
- cGMP · Identifier: cGMP accreditation
|
|---|